Opposite effects of anthelmintic treatment on microbial infection at individual versus population scales

Science

Volumn 347, Issue 6218, 2015, Pages 175-177

  Ezenwa, Vanessa O ^a   Jolles, Anna E ^b  

^a UNIVERSITY OF GEORGIA   (United States)

^b OREGON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FENBENDAZOLE; ANTINEMATODAL AGENT;

DISEASE TREATMENT; FITNESS; IMMUNE RESPONSE; MAMMAL; MICROBIAL ACTIVITY; MORTALITY; PARASITIC DISEASE; PATHOGEN; TUBERCULOSIS;

AFRICAN BUFFALO; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL PARASITOSIS; ARTICLE; BOVINE TUBERCULOSIS; CONTROLLED STUDY; DRUG EFFECT; FEMALE; IMMUNITY; INCIDENCE; MICROBIAL POPULATION DYNAMICS; MORTALITY; NONHUMAN; PRIORITY JOURNAL; ANIMAL; BOVINAE; BUFFALO; COMMUNICABLE DISEASE; DRUG EFFECTS; GENETICS; HELMINTHIASIS, ANIMAL; HOST PATHOGEN INTERACTION; IMMUNOLOGY; MICROBIOLOGY; MIXED INFECTION; MYCOBACTERIUM BOVIS; PARASITOLOGY; PHYSIOLOGY; REPRODUCTIVE FITNESS; TH1 CELL; VETERINARY;

BOVINAE; SYNCERUS CAFFER;

ANIMALS; ANTINEMATODAL AGENTS; BUFFALOES; CATTLE; COINFECTION; COMMUNICABLE DISEASES; FEMALE; FENBENDAZOLE; GENETIC FITNESS; HELMINTHIASIS, ANIMAL; HOST-PATHOGEN INTERACTIONS; INCIDENCE; MYCOBACTERIUM BOVIS; TH1 CELLS; TUBERCULOSIS, BOVINE;

EID: 84923265824     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.1261714     Document Type: Article

References (28)

1. R. L. Pullan, J. L. Smith, R. Jasrasaria, S. J. Brooker, Parasites Vectors 7, 37 (2014).
2. J. Charlier, M. van der Voort, F. Kenyon, P. Skuce, J. Vercruysse, Trends Parasitol. 30, 361-367 (2014).
3. H. J. McSorley, R. M. Maizels, Clin. Microbiol. Rev. 25, 585-608 (2012).
4. P. Salgame, G. S. Yap, W. C. Gause, Nat. Immunol. 14, 1118-1126 (2013).
5. T. A. Reese et al., Science 345, 573-577 (2014).
6. A. L. Chenine et al., PLOS Negl. Trop. Dis. 2, e265 (2008).
7. L. Su et al., Infect. Immun. 82, 3855-3866 (2014).
8. A. J. Lankowski et al., PLOS Negl. Trop. Dis. 8, e3036 (2014).
9. P. J. George et al., J. Immunol. 190, 5161-5168 (2013).
10. J. L. Walson, B. R. Herrin, G. John-Stewart, Cochrane Database Syst. Rev. (3): CD006419 (2009).
11. W. Rafi, R. Ribeiro-Rodrigues, J. J. Ellner, P. Salgame, Curr. Opin. HIV AIDS 7, 239-244 (2012).
12. P. J. Hotez et al., PLOS Med. 3, e102 (2006).
13. J. Noblick, R. Skolnik, P. J. Hotez, PLOS Negl. Trop. Dis. 5, e1022 (2011).
14. G. Borkow, C. Teicher, Z. Bentwich, PLOS Negl. Trop. Dis. 1, e160 (2007).
15. Materials and methods are available as supplementary materials on Science Online.
16. A. E. Jolles, V. O. Ezenwa, R. S. Etienne, W. C. Turner, H. Olff, Ecology 89, 2239-2250 (2008).
17. V. O. Ezenwa, R. S. Etienne, G. Luikart, A. Beja-Pereira, A. Jolles, Am. Nat. 176, 613-624 (2010).
18. J. L. Flynn, J. Chan, Annu. Rev. Immunol. 19, 93-129 (2001).
19. M. D. Welsh et al., Immunology 114, 101-111 (2005).
20. R. van Crevel, T. H. Ottenhoff, J. W. van der Meer, Clin. Microbiol. Rev. 15, 294-309 (2002).
21. A. R. Martineau et al., J. Clin. Invest. 117, 1988-1994 (2007).
22. R. G. Bengis, Tuberculosis, M. E. Fowler, R. E. Miller, Eds. (W. B. Saunders, Philadelphia, 1999).
23. R. M. Anderson, R. M. May, Infectious Diseases of Humans: Dynamics and Control (Oxford University Press, Oxford, 1991).
24. A. Mulu, M. Maier, U. G. Liebert, Int. J. Infect. Dis. 17, e897-e901 (2013).
25. N. Apiwattanakul, P. G. Thomas, R. E. Kuhn, D. R. Herbert, J. A. McCullers, Med. Microbiol. Immunol. (Berl.) 203, 357-364 (2014).
26. T. W. Jia, S. Melville, J. Utzinger, C. H. King, X. N. Zhou, PLOS Negl. Trop. Dis. 6, e1621 (2012).
27. D. A. Bundy, J. L. Walson, K. L. Watkins, Trends Parasitol. 29, 142-148 (2013).
28. P. J. Hotez, PLOS Negl. Trop. Dis. 7, e2570 (2013).